CoVP Communications
This page contains COVID-19 Vaccine communications sent out from the Connecticut Department of Public Health Immunization Program.If you would like to sign up to receive these communications directly, please send an email to Dph.immunizations@ct.gov with the subject line “Subscribe to COVID-19 Program communications”.
- Pfizer BLA, Novavax EUA, Fall Booster Updates July 20, 2022 7/20/22
- Slides from the COVID-19 Vaccine Provider Update Call for July 6, 2022 7/6/22
- Moderna expansion for children 6 through 17 years of age 6/27/22
- Young Pediatric Vaccine Provider Webinars 6/21/22
- COVID-19 Vaccine Recommendation Expanded to Children 6 months through 4 Years of Age, June 19, 2022 6/19/22
- Slides from the COVID-19 Vaccine Provider Update Call for June 1 2022 6/1/22
- [Urgent] Action Required: Pre-ordering for COVID-19 Vaccine for Children Age 6 months through 5 years - Week 1 5/31/22
- COVID-19 Vaccine Provider Update on Pediatric (under 5) Roll out and Planning 5/26/22
- 5.24.22 Summer Provider Survey: COVID-19 Ages 0-4 Vaccination Planning 5/24/22
- Expanded COVID-19 Booster Recommendation to Children 5-11 Years of Age, May 19, 2022 5/19/22
- CDC COCA Call: Clinical Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology - May 19, 2022, 2:00 PM – 3:00 PM ET 5/12/22
- CDC HAN: Updated Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology 5/11/22
- FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals May 6, 2022 5/6/22
- Slides from the COVID-19 Vaccine Provider Update Call for May 4, 2022 5/4/22
- COVID-19 Vaccine Pediatric (age 4 and under) Anticipated Roll out and Program Updates May 3, 2022 5/3/22
- CDC Health Alert Network (HAN) Health Advisory 463: Updated Information on Availability and Use of Treatments for Outpatients with Mild to Moderate COVID-19 Who are at Increased Risk for Severe Outcomes of COVID-19 4/25/22
- Slides from the COVID-19 Vaccine Provider Update Call for April 6, 2022 4/6/22
- COVID-19 Interim Clinical Considerations Updated and Moderna Product Clarification 4/4/22
Return to Immunizations Homepage